Metabolomic Profiling Reveals Biochemical Pathways and Biomarkers Associated with Pathogenesis in Cystic Fibrosis Cells

Cystic fibrosis (CF) is a life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. To gain an understanding of the epithelial dysfunction associated with CF mutations and discover biomarkers for therapeutics development, untargeted metabolomic analysis was performed on primary human airway epithelial cell cultures from three separate cohorts of CF patients and non-CF subjects. Statistical analysis revealed a set of reproducible and significant metabolic differences between the CF and non-CF cells. Aside from changes that were consistent with known CF effects, such as diminished cellular regulation against oxidative stress and osmotic stress, new observations on the cellular metabolism in the disease were generated. In the CF cells, the levels of various purine nucleotides, which may function to regulate cellular responses via purinergic signaling, were significantly decreased. Furthermore, CF cells exhibited reduced glucose metabolism in glycolysis, pentose phosphate pathway, and sorbitol pathway, which may further exacerbate oxidative stress and limit the epithelial cell response to environmental pressure. Taken together, these findings reveal novel metabolic abnormalities associated with the CF pathological process and identify a panel of potential biomarkers for therapeutic development using this model system.

[1]  P. Davis,et al.  Cystic fibrosis since 1938. , 2006, American journal of respiratory and critical care medicine.

[2]  J. Bargon,et al.  A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis , 2009, European journal of medical research.

[3]  J. Goin,et al.  Energy Expenditure and Genotype of Children with Cystic Fibrosis , 1994, Pediatric Research.

[4]  Karen A Robinson,et al.  Pulmonary Perspective Cystic Fibrosis Pulmonary Guidelines Treatment of Pulmonary Exacerbations , 2009 .

[5]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[6]  Sylvia Notenboom,et al.  Glutathione dysregulation and the etiology and progression of human diseases , 2009, Biological chemistry.

[7]  H. Quinton,et al.  Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. , 2008, Journal of the American Dietetic Association.

[8]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[9]  W. Guggino,et al.  New insights into cystic fibrosis: molecular switches that regulate CFTR , 2006 .

[10]  M. Tomita,et al.  Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption* , 2006, Journal of Biological Chemistry.

[11]  J. Pilewski,et al.  Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. , 2000, American journal of physiology. Cell physiology.

[12]  M. Milburn,et al.  Analysis of the adult human plasma metabolome. , 2008, Pharmacogenomics.

[13]  Lining Guo,et al.  Untargeted Metabolomic Profiling as an Evaluative Tool of Fenofibrate-Induced Toxicology in Fischer 344 Male Rats , 2009, Toxicologic pathology.

[14]  B. Verrier,et al.  Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channel , 1998, British journal of pharmacology.

[15]  A. Ghio,et al.  Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[16]  David K. Meyerholz,et al.  Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs , 2008, Science.

[17]  C. Folli,et al.  Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells. , 2000, American journal of physiology. Cell physiology.

[18]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[19]  J. Clancy,et al.  Adenosine receptors, cystic fibrosis, and airway hydration. , 2009, Handbook of experimental pharmacology.

[20]  R. Boucher,et al.  CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship , 1993, Nature.

[21]  B. Day,et al.  Role for Cystic Fibrosis Transmembrane Conductance Regulator Protein in a Glutathione Response to Bronchopulmonary Pseudomonas Infection , 2004, Infection and Immunity.

[22]  S. Hilton,et al.  Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled, observational study. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[23]  N. Alexis,et al.  Extracellular purines are biomarkers of neutrophilic airway inflammation , 2008, European Respiratory Journal.

[24]  N. Høiby,et al.  Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation , 2005, Antimicrobial Agents and Chemotherapy.

[25]  D. J. Rose,et al.  Metabolomics for early detection of drug-induced kidney injury: review of the current status. , 2009, Bioanalysis.

[26]  Jinglan Zhou,et al.  Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 , 2009, Proceedings of the National Academy of Sciences.

[27]  R. Crystal,et al.  Systemic deficiency of glutathione in cystic fibrosis. , 1993, Journal of applied physiology.

[28]  P. Factor,et al.  Adenosine regulation of alveolar fluid clearance , 2007, Proceedings of the National Academy of Sciences.

[29]  F. Lang.  Mechanisms and Significance of Cell Volume Regulation , 2006, Journal of the American College of Nutrition.

[30]  A. Kowalewska,et al.  Kynurenine and Its Metabolites—Kynurenic Acid and Anthranilic Acid are Associated With Soluble Endothelial Adhesion Molecules and Oxidative Status in Patients With Chronic Kidney Disease , 2009, The American journal of the medical sciences.

[31]  F. Collins,et al.  Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. , 1991, Science.

[32]  P. Thomas,et al.  Organic Solutes Rescue the Functional Defect in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator* , 2003, Journal of Biological Chemistry.

[33]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Herzenberg,et al.  High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Welsh,et al.  Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. , 1993, Human gene therapy.

[36]  M. Kendall.  Statistical Methods for Research Workers , 1937, Nature.

[37]  P. Yancey,et al.  Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses , 2005, Journal of Experimental Biology.

[38]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[39]  J. Stamler,et al.  Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[40]  T. Flotte,et al.  The Short Apical Membrane Half-life of Rescued ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Results from Accelerated Endocytosis of ΔF508-CFTR in Polarized Human Airway Epithelial Cells* , 2005, Journal of Biological Chemistry.

[41]  J. Stamler,et al.  S-Nitrosylating Agents: A Novel Class of Compounds That Increase Cystic Fibrosis Transmembrane Conductance Regulator Expression and Maturation in Epithelial Cells , 2006, Molecular Pharmacology.

[42]  B. Gaston,et al.  Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. , 1999, The Journal of pediatrics.

[43]  Seiko F. Okada,et al.  Coordinated release of nucleotides and mucin from human airway epithelial Calu‐3 cells , 2007, The Journal of physiology.

[44]  M. Zaccolo,et al.  Spatiotemporal Coupling of cAMP Transporter to CFTR Chloride Channel Function in the Gut Epithelia , 2007, Cell.

[45]  H. Mori,et al.  Molecular Basis of Formaldehyde Detoxification , 2006, Journal of Biological Chemistry.

[46]  J. Widdicombe,et al.  Culture and transformation of human airway epithelial cells. , 1995, The American journal of physiology.

[47]  B. Grubb.  Ion transport across the normal and CF neonatal murine intestine. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[48]  S. Hilton,et al.  A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis. , 2005, Chest.

[49]  V. Hudson.  Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. , 2001, Free radical biology & medicine.

[50]  R. Beger,et al.  Monitoring the health to disease continuum with global metabolic profiling and systems biology. , 2006, Pharmacogenomics.

[51]  S. Randell,et al.  Novel human bronchial epithelial cell lines for cystic fibrosis research. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[52]  H. Forman,et al.  Abnormal glutathione transport in cystic fibrosis airway epithelia. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[53]  B. Gaston,et al.  Activation of chloride transport in CF airway epithelial cell lines and primary CF nasal epithelial cells by S-nitrosoglutathione , 2006, Respiratory research.

[54]  V. Hudson.  New Insights Into the Pathogenesis of Cystic Fibrosis , 2004, Treatments in respiratory medicine.

[55]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.